Inventor · disambiguated record
Dario A. Vignali
Also filed as: VIGNALI DARIO · VIGNALI DARIO A · VIGNALI DARIO A A · VIGNALI DARIO AA
8 granted patents·9 pending applications·91 citations·filing 2004–2023
86Inventor score
Files withUNIV JOHNS HOPKINS5ST JUDE CHILDREN’S RES HOSPITAL4ST JUDE CHILDRENS RES HOSPITAL3VIGNALI DARIO AA2PARDOLL DREW M1
Top patents by PatentIndex Score
17 records- 0196US9005629B2Method for treating cancer with an antibody to CD223 proteinUNIV JOHNS HOPKINS·Filed 2012·Granted Apr 14, 2015·42 cites·4 claims
- 0293US8551481B2Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibodyPARDOLL DREW M·Filed 2009·Granted Oct 8, 2013·41 cites·6 claims
- 0384US2024174747A1T cell regulationUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 0479US10787513B2Methods for treatment comprising an antibody that binds CD223 proteinUNIV JOHNS HOPKINS·Filed 2015·Granted Sep 29, 2020·1 cites·25 claims
- 0574US2021230275A1T cell regulationUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0673US9217135B2T effector cells modulated via interleukin 35 and methods of culturing sameST JUDE CHILDRENS RES HOSPITAL·Filed 2014·Granted Dec 22, 2015·1 cites·4 claims
- 0772US10934354B2Methods of increasing T cell immune response in the treatment of cancerUNIV JOHNS HOPKINS·Filed 2018·Granted Mar 2, 2021·0 cites·20 claims
- 0871US8784807B2Method of inhibiting regulatory T-cell activity by administering an antibody that inhibits interleukin 35VIGNALI DARIO·Filed 2007·Granted Jul 22, 2014·2 cites·4 claims
- 0970US9518113B2Monoclonal antibodies to interleukin 35 and methods of use thereof to inhibit regulatory T cell functionST JUDE CHILDREN'S RES HOSPITAL·Filed 2015·Granted Dec 13, 2016·1 cites·23 claims
- 1069US9540439B2Therapies based on control of regulatory T cell stability and function via a neuropilin-1:semaphorin axisST JUDE CHILDREN'S RES HOSPITAL·Filed 2013·Granted Jan 10, 2017·3 cites·16 claims
- 1168US2014127226A1T Cell RegulationST JUDE S CHILDREN S RES HOSPITAL INC·Filed 2013·Application pending·0 cites
- 1264US2006240024A1T cell regulationST JUDE CHILDRENS RES HOSPITAL·Filed 2004·Application pending·0 cites
- 1356US2017073410A1Monoclonal antibodies to interleukin 35 and methods of use thereof to inhibit regulatory t cell functionST JUDE CHILDREN'S RES HOSPITAL·Filed 2016·Application pending·0 cites
- 1449US2020010552A1Therapies based on control of regulatory t cell stability and function via a neuropilin-1:semaphorin axisST JUDE CHILDRENS RES HOSPITAL·Filed 2019·Application pending·0 cites
- 1544US2013183326A9Methods and compositions for modulating the activity of the interleukin-35 receptor complexVIGNALI DARIO AA·Filed 2010·Application pending·0 cites
- 1641US2017137524A1Therapies based on control of regulatory t cell stability and function via a neuropilin-1:semaphorin axisST JUDE CHILDREN'S RES HOSPITAL·Filed 2016·Application pending·0 cites
- 1737US2012058096A1Compositions and methods for generating interleukin-35-induced regulatory t cellsVIGNALI DARIO AA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →